- Active not recruitingPHASE2
Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
This study is for people with certain immune conditions (PIDs) linked to a specific problem with their immune cells. It's an extension of a previous study testing a medicine called leniolisib. The main goal is to check its long-term safety and how well it works for these conditions.
For: PIDs Linked to PI3KUnited States · Spain · United Kingdom - Active not recruitingPHASE3
Pediatric Patients Aged 1 to 6 Years With APDS
This study is looking for children aged 1 to 6 with a rare condition called APDS. It will test a new medicine called leniolisib to see if it's safe and helps improve their health, with a focus on long-term effects.
For: APDSUnited States · Japan · Portugal - Active not recruitingPHASE2
Leniolisib for Immune Dysregulation in CVID
This study is looking at a new medicine called leniolisib for people aged 12-75 with Common Variable Immunodeficiency (CVID). It aims to see if the drug is safe and well-tolerated, and if it can help with the immune problems sometimes seen in CVID.
For: Common Variable Immunodeficiency (CVID)United States · Spain · United Kingdom